Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis

被引:8
|
作者
Konen, Franz Felix [1 ]
Hannich, Malte Johannes [2 ]
Schwenkenbecher, Philipp [1 ]
Grothe, Matthias [3 ]
Gag, Konrad [3 ]
Jendretzky, Konstantin Fritz [1 ]
Gingele, Stefan [1 ]
Suhs, Kurt-Wolfram [1 ]
Witte, Torsten [4 ]
Skripuletz, Thomas [1 ]
Suesse, Marie [3 ]
机构
[1] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany
[2] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany
[3] Univ Med Greifswald, Dept Neurol, D-17475 Greifswald, Germany
[4] Hannover Med Sch, Dept Rheumatol & Immunol, D-30625 Hannover, Germany
关键词
multiple sclerosis; free light chains kappa; cerebrospinal fluid; humoral immune response; immunoglobulins; oligoclonal bands; MRZ reaction; early onset MS; late onset MS; progressive MS; FREE LIGHT-CHAINS; MRZ REACTION; QUANTIFICATION; IMPAIRMENT; ANTIBODIES; PATTERNS; PROGRESS; BLOOD; SERUM;
D O I
10.3390/biomedicines10071629
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The intrathecal humoral response is the characteristic diagnostic finding in the cerebrospinal fluid (CSF) analysis of patients with multiple sclerosis (MS). Although the average age of MS patients increases, little is known about the sensitivity of diagnostic markers in elderly MS patients. Methods: In this retrospective two-center study, intrathecal free light chains kappa fraction (FLCk IF) and oligoclonal bands (OCB) were studied in a large cohort of patients with early and late onset relapsing (RMS) and progressive (PMS) MS. Furthermore, the humoral immune profile in CSF was analyzed, including the polyspecific intrathecal immune response measured as the MRZ reaction. Results: While the frequency of CSF-specific OCB did not differ between early and late onset RMS and PMS, the sensitivity of positive FLCk IF and absolute FLCk IF values were lower in PMS. The positivity of the MRZ reaction was equally frequent in early and late onset RMS and PMS. PMS patients had higher local IgA concentrations than RMS patients (p = 0.0123). Conclusions: OCB are slightly superior to FLCk IF in progressive MS in terms of sensitivity for detecting intrathecal immunoglobulin synthesis. The MRZ reaction, as the most specific parameter for MS, is also applicable in patients with late onset and progressive MS.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] CEREBROSPINAL-FLUID IN MULTIPLE-SCLEROSIS
    LOWENTHAL, A
    KARCHER, D
    CLINICAL NEUROSCIENCE, 1994, 2 (3-4) : 211 - 214
  • [22] Decreased Level of sRAGE in the Cerebrospinal Fluid of Multiple Sclerosis Patients at Clinical Onset
    Glasnovic, Anton
    Cvija, Hrvoje
    Stojic, Maristela
    Tudoric-Deno, Ivana
    Ivcevic, Sanja
    Romic, Dominik
    Ticinovic, Nino
    Vuletic, Vladimira
    Lazibat, Ines
    Grcevic, Danka
    NEUROIMMUNOMODULATION, 2014, 21 (05) : 226 - 233
  • [23] Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis
    Khalil, M.
    Renner, A.
    Langkammer, C.
    Enzinger, C.
    Ropele, S.
    Stojakovic, T.
    Scharnagl, H.
    Bachmaier, G.
    Pichler, A.
    Archelos, J. J.
    Fuchs, S.
    Seifert-Held, T.
    Fazekas, F.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (12) : 1560 - 1568
  • [24] Late onset multiple sclerosis
    Arias, M.
    Dapena, D.
    Arias-Rivas, S.
    Costa, E.
    Lopez, A.
    Prieto, J. M.
    Corredera, E.
    NEUROLOGIA, 2011, 26 (05): : 291 - 296
  • [25] Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis
    Fialova, Lenka
    Bartos, Ales
    Svarcova, Jana
    Zimova, Denisa
    Kotoucova, Jolana
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 259 (1-2) : 81 - 87
  • [26] Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
    Khalil, M.
    Riedlbauer, B.
    Langkammer, C.
    Enzinger, C.
    Ropele, S.
    Stojakovic, T.
    Scharnagl, H.
    Culea, V.
    Petzold, A.
    Teunissen, C. E.
    Archelos, J-J
    Fuchs, S.
    Fazekas, F.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (12) : 1569 - 1577
  • [27] Cerebrospinal fluid biomarkers in multiple sclerosis
    Tumani, Hayrettin
    Hartung, Hans-Peter
    Hemmer, Bernhard
    Teunissen, Charlotte
    Deisenhammer, Florian
    Giovannoni, Gavin
    Zettl, Uwe K.
    NEUROBIOLOGY OF DISEASE, 2009, 35 (02) : 117 - 127
  • [28] Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
    Awad, Amer
    Hemmer, Bernhard
    Hartung, Hans-Peter
    Kieseier, Bernd
    Bennett, Jeffrey L.
    Stuve, Olaf
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 219 (1-2) : 1 - 7
  • [29] Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
    Fitzner, Brit
    Hecker, Michael
    Zettl, Uwe Klaus
    AUTOIMMUNITY REVIEWS, 2015, 14 (10) : 903 - 913
  • [30] Cerebrospinal fluid proteomics in multiple sclerosis
    Kroksveen, Ann C.
    Opsahl, Jill A.
    Guldbrandsen, Astrid
    Myhr, Kjell-Morten
    Oveland, Eystein
    Torkildsen, Oivind
    Berven, Frode S.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2015, 1854 (07): : 746 - 756